HCV Genotype 1 - 6
HCV Subtypes Variants

Genotype 1 and 4 Articles

Genotype 2 and 3 Articles

Genotype 5 and 6 Articles

Genotypes 1 and 4

Response to Pegylated Interferon plus Ribavirin in Asian Patients with Genotype 1 Chronic Hepatitis C - 10/21/2008

24 Weeks of Pegylated Interferon plus Ribavirin May Be Sufficient for Selected Genotype 1/4 Chronic Hepatitis C Patients with Rapid Response - 10/14/08

74 Percent of Genotype 1 HCV Patients in Experimental HCV PI Boceprevir Phase II Study Achieve Sustained Virologic Response (SVR) at 48 Weeks - 8/05/2008

Adequate Ribavirin Exposure after the First Dose Predicts Sustained Virological Response to Hepatitis C Treatment in Genotype 1 Patients - 7/08/08

HCV Genotype 1 Patients with High Viral Load Do Better with 48 vs 24 Weeks of Treatment, despite Rapid Virological Response - 7/04/08

Vertex and Tibotec Start Phase 3 Study of Telaprevir for Treatment-Naive Genotype 1 Hepatitis C Patients - 3/21/08

Pegylated Interferon plus Ribavirin in the Treatment of Chronic Hepatitis C Genotype 4 - 1/08/08

Genotypes 2 and 3


Combination Therapy with Investigational HCV Polymerase Inhibitor R7128 Produces Rapid Response in Patients with Genotype 2/3 HCV - 9/12/2008

Body Weight Affects Relapse Rates in Latinos with Genotype 2/3 Hepatitis C Treated with Pegylated Interferon Alfa-2a (Pegasys) plus Ribavirin - 8/12/2008

Eight Weeks of Pegylated Interferon plus Ribavirin for Genotype 2 Chronic HCV Patients with Rapid Virological Response (RVR) - 8/05/2008

12- Versus 24-week Treatment with Pegylated Interferon plus Ribavirin for Genotype 2 or 3 Chronic Hepatitis C Patients - 7/11/08

European Commission Approves Shorter 16-week Course of Pegasys plus Ribavirin for Rapid Responders with HCV Genotypes 2 or 3 and Low Viral Load - 7/04/08

Studies Explore Lower Doses of Pegylated Interferon and Ribavirin for People with Hepatitis C Virus Genotypes 2 or 3 - 7/08/08

Limitations of an 8-week Course of Pegylated interferon plus Ribavirin for Genotype 2 Hepatitis C Patients with Rapid Virological Response - 4/24/08

Genetic Variations in HCV Genotype 3 Core Protein Promote Liver Fat Accumulation - 2/26/08

Asians with HCV Genotype 3 Do Not Respond as Well as Caucasians to Interferon-based Therapy - 2/19/08

HCV Genotypes 2 and 3 Do Not Respond the Same to Interferon-based Treatment - 1/29/08

Insulin Resistance Linked to Lower Treatment Response in Genotype 2/3 Patients - 2/01/08

Liver Steatosis Is Common in Hepatitis C Patients, Especially Those with Genotype 3 - 2/01/08

Duration of Pegylated Interferon plus Ribavirin for HCV Genotypes 2 and 3 - 1/29/08

HCV Genotypes 2 and 3 Do Not Respond the Same to Interferon-based Treatment - 1/29/08

Genotypes 5 and 6 Articles (Genotype 5 - Africa / Genotype 6 - South East Asia)

Individuals with HCV Genotype 6 Respond Well to Pegylated Interferon plus Ribavirin - 10/14/08

Epidemiology and Treatment Response of Genotype 5 HCV; Researchers Find New Seventh Genotype - 11/27/07

HCV-796 Plus PegIntron Shows Greater Antiviral Activity Across All HCV Genotypes Than Either Agent Used Alone  - 5/22/07